Dichotomic response patterns to PD-1 blockade with cemiplimab in a patient with multiple squamous cell carcinomas

J Eur Acad Dermatol Venereol. 2023 Apr;37(4):e547-e549. doi: 10.1111/jdv.18705. Epub 2022 Nov 7.

Authors

Giulia Bazzacco¹, Enrico Zelin¹, Ludovica Toffoli¹, Claudio Conforti¹, Nicola di Meo¹, Dahlia Fedele², Iris Zalaudek¹

Affiliations

¹ Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, Italy.
² Skin Cancer Unit, Department of Medical Oncology, Maggiore Hospital of Trieste, Trieste, Italy.

PMID: 36305888
DOI: 10.1111/jdv.18705

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Carcinoma, Squamous Cell* / drug therapy
Carcinoma, Squamous Cell* / pathology
Humans
Programmed Cell Death 1 Receptor
Skin Neoplasms* / drug therapy
Skin Neoplasms* / pathology

Substances

cemiplimab
Programmed Cell Death 1 Receptor
Antibodies, Monoclonal, Humanized